Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06398847 · ClinicalTrials.gov registry record · NA
Virtual Reality (VR) Self-Hypnosis Software
A NA study of Musculoskeletal Pain and Neuropathic Pain, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06398847: Recruiting NA study of Musculoskeletal Pain and Neuropathic Pain, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06398847 is a NA study of Musculoskeletal Pain and Neuropathic Pain that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 25 participants, below the 155-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06398847, a NA study of Musculoskeletal Pain and Neuropathic Pain, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.
Primary Outcome
Feasibility of self-hypnosis software using VR devices as measured by frequency of use. The device software will have an ability to determine the number of times each participant used the self-hypnosis software during the 21-day period.
Conditions Studied
Interventions
- DEVICE Virtual Reality headset
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-01-31 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06398847 shows while recruiting
NCT06398847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 155-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Musculoskeletal Pain appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality headset is the first listed.
NCT06398847 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06398847 about?
NCT06398847 is a clinical study titled "Virtual Reality (VR) Self-Hypnosis Software". This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sina...
What is the current status of trial NCT06398847?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-01-31. Estimated completion is 2026-06-30.
What conditions does trial NCT06398847 study?
This clinical trial studies the following conditions: Musculoskeletal Pain, Neuropathic Pain, Neuralgia.
What interventions are being tested in trial NCT06398847?
The interventions under investigation include: Virtual Reality headset (DEVICE).
Who is sponsoring clinical trial NCT06398847?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06398847 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06398847's enrollment target sits among peer trials
25 33rd of 37 higher than 5 of 37 other Musculoskeletal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Mechanisms and Modulation of Pain Modulatory Capacity
RECRUITING · NA
-
Equipping Patients Using Interventions for Pain and Depression
RECRUITING · NA
-
Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI